Caylee's Hope Stop Leukemia4 min. 31 sec.
Story of a 4 year old girl who lost her battle with Leukemia in only 5 days.
Watch the Video
|
Clinical Trials Update: Dec. 22, 2006
Volunteers 18 or older with B-cell chronic lymphocytic leukemia who have not been treated for the disease with a cell-depleting aim may be eligible for this clinical trial. The research sites are in California, New York, and Texas.
Read the Article
|
Health Tip: Don't Ignore Bleeding Gums
Bleeding gums are a sign that you may be at risk of dental or periodontal disease. Bleeding gums are often caused by a buildup of plaque along the gumline, the U.S. National Library of Medicine says. Without proper dental care and treatment, plaque may harden to form tartar that is difficult to remove. Gingivitis, or inflammation of the gums, may develop if your gums tend to bleed
Read the Article
|
Clinical Trials Update: Dec. 29, 2006
People who have had one of the bone marrow failures syndromes listed below are asked to participate in a research study. If you are at least 18 and have one of the following, you may qualify: Aplastic Anemia (pancytopenia with a hypocellular marrow and no evidence of leukemia), Myelodysplastic Syndromes, Refractory Anemia, Refractory Cytopenia with Multilineage Dysplasia, 5q-Syndrome, or other bone marrow failure syndromes.
Read the Article
|
Clinical Trials Update: Jan. 19, 2007
This study will evaluate an investigational medication to manage endometriosis. Volunteers 18-46 who have been diagnosed with endometriosis by laparoscopy and have recurring pain associated with the condition may qualify. The research site is in Tucson, Ariz.
Read the Article
|
Prostate Cancer Trial Halted Due to 3 Cases of Leukemia
A trial testing whether the chemotherapy drug mitoxantrone would benefit men with prostate cancer has been stopped because three of the 488 patients who received the drug developed leukemia.
Read the Article
|
New Drug Fights Deadly Fungal Infections
Two studies have found that a new drug, Noxafil, prevents fungal infections better than existing medications among high-risk patients and also seems to have fewer side effects. Invasive fungal infections are a leading cause of death among people undergoing chemotherapy for blood cancers, bone marrow transplants or organ transplants and who have low white blood cell counts as a result.
Read the Article
|
Clinical Trials Update: Jan. 25, 2007
This is an open-label, randomized study for people with relapsed, follicular B-cell lymphoma. Volunteers at least 18 who have histologically confirmed follicular B-cell lymphoma, have a B-cell population that is CD-20 positive, have received prior therapy for the condition, and do not have CNS lymphoma, chronic lymphocytic leukemia, or small lymphocytic lymphoma may be eligible. The research sites are located across the United States.
Read the Article
|
Test May Help Guide Blood Cancer Treatment
Scientists have developed a new test to spot a blood cancer that is vulnerable to a promising type of experimental drug that promotes cancer cell death. The test was developed by scientists at the Dana Farber Cancer Institute in Boston. Using the test, they found that chronic lymphocytic leukemia (CLL) is an "easy mark" for the experimental drug ABT-737.
Read the Article
|
Potential Method of Blocking Cancer Cell Growth Identified
A new approach that uses small molecules to target cancer cells may be able to disrupt the cells' function and stop them from growing without affecting normal cells, researchers report. Using these molecules to block other proteins on the cells' surface could lead to future cancer treatments, according to the report in the Jan. 26 issue of Cell.
Read the Article
|
Health Tip: Donating Bone Marrow
A bone marrow transplant can be a lifesaver for someone with leukemia or other diseases of the blood. According to the National Marrow Donor Program, the donor is anesthetized, and a needle is inserted into the pelvic bone to withdraw the liquid bone marrow. Then, many donors receive a transfusion of their own previously donated blood. Within about six weeks, the donor's body has completely replenished the marrow that was donated.
Read the Article
|
Scientists Find Cancer Stem Cells in Pancreatic Tumors
Researchers have for the first time identified stem cells linked to pancreatic cancer. The study, by scientists at the University of Michigan Comprehensive Cancer Center, could help in the development of new treatments for this deadly form of cancer, which has the worst survival rate of any major malignancy.
Read the Article
|
Aplastic Anemia: A Rare Disease With a Better Prognosis
Aplastic anemia, a disease of the bone marrow, is a rare disorder in the United States. Only three of every 1 million Americans will be diagnosed with the condition this year, the National Marrow Donor Program reports. Despite that rarity, this once-fatal disease has become far more treatable as physicians have honed in on practices that can prolong life and ease suffering.
Read the Article
|
Natural Immune-System Molecule Helps Shield Against HIV
U.S. AIDS researchers are getting a better understanding of how an immune system molecule called interleukin-7 keeps cells from dying, even when they're under attack from HIV. Clinical trials are already under way in which scientists are boosting HIV-positive patients' IL-7 levels to improve their immune health.
Read the Article
|
|
Page: 1 2 3 4
Members currently browsing this category:
|
